IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Regeneron Pharmaceuticals, Inc.

Q4 2025 Holdings

Filed 2026-02-06 | 2 holdings | $33.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Intellia Therapeutics, Inc.(NTLA)Common Stock45826J105$33.3M3,702,99598.5%
Adicet Bio, Inc.(TORCEUR)Common Stock007002108$509.5K60,5111.5%